DOHA: Two important health initiatives aimed at controlling and preventing the impact of lifestyle diseases were launched yesterday during the Qatar ...
As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...
MEDIA RELEASE Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One of several biosimilar value drivers for SandozSandoz ...